BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16150819)

  • 1. PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.
    Kessen UA; Schaloske RH; Stephens DL; Killermann Lucas K; Dennis EA
    J Lipid Res; 2005 Nov; 46(11):2488-96. PubMed ID: 16150819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells.
    Barbour SE; Dennis EA
    J Biol Chem; 1993 Oct; 268(29):21875-82. PubMed ID: 8408042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells.
    Balboa MA; Shirai Y; Gaietta G; Ellisman MH; Balsinde J; Dennis EA
    J Biol Chem; 2003 Nov; 278(48):48059-65. PubMed ID: 12963740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages.
    Schaloske RH; Provins JW; Kessen UA; Dennis EA
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):64-75. PubMed ID: 15708354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulative effect of cadmium on prostaglandin E2 production in primary mouse osteoblastic cells.
    Miyahara T; Tonoyama H; Watanabe M; Okajima A; Miyajima S; Sakuma T; Nemoto N; Takayama K
    Calcif Tissue Int; 2001 Mar; 68(3):185-91. PubMed ID: 11351503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide.
    Lister MD; Glaser KB; Ulevitch RJ; Dennis EA
    J Biol Chem; 1989 May; 264(15):8520-8. PubMed ID: 2498315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis.
    Roshak A; Sathe G; Marshall LA
    J Biol Chem; 1994 Oct; 269(42):25999-6005. PubMed ID: 7929310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s.
    Shinohara H; Balboa MA; Johnson CA; Balsinde J; Dennis EA
    J Biol Chem; 1999 Apr; 274(18):12263-8. PubMed ID: 10212194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytoplasmic and secretory phospholipase A2 in intestinal epithelial cell prostaglandin E2 formation.
    Grossman EM; Longo WE; Mazuski JE; Panesar N; Kaminski DL
    Int J Surg Investig; 2000; 1(6):467-76. PubMed ID: 11729854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes.
    Balsinde J; Barbour SE; Bianco ID; Dennis EA
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11060-4. PubMed ID: 7972009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2.
    Dieter P; Kolada A; Kamionka S; Schadow A; Kaszkin M
    Cell Signal; 2002 Mar; 14(3):199-204. PubMed ID: 11812647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2alpha production by bovine endometrial epithelial cells.
    Tithof PK; Roberts MP; Guan W; Elgayyar M; Godkin JD
    Reprod Biol Endocrinol; 2007 Apr; 5():16. PubMed ID: 17459165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2.
    Glaser KB; Asmis R; Dennis EA
    J Biol Chem; 1990 May; 265(15):8658-64. PubMed ID: 2160463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human synovial fibroblast 85 kDa phospholipase A2 by antisense reduces interleukin-1 beta induced prostaglandin E2.
    Roshak A; Mochan E; Marshall LA
    J Rheumatol; 1996 Mar; 23(3):420-7. PubMed ID: 8832976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phospholipase A2 release by elicited-peritoneal macrophage and its relationship to eicosanoid production.
    Marshall LA; Bolognese B; Roshak A
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):295-313. PubMed ID: 7812679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature macrophage cell lines exhibit variable responses to LPS.
    Barbour SE; Wong C; Rabah D; Kapur A; Carter AD
    Mol Immunol; 1998 Oct; 35(14-15):977-87. PubMed ID: 9881693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages.
    Bianco ID; Balsinde J; Beltramo DM; Castagna LF; Landa CA; Dennis EA
    FEBS Lett; 2000 Jan; 466(2-3):292-4. PubMed ID: 10682846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells.
    Reddy ST; Winstead MV; Tischfield JA; Herschman HR
    J Biol Chem; 1997 May; 272(21):13591-6. PubMed ID: 9153207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts.
    Kuwata H; Nakatani Y; Murakami M; Kudo I
    J Biol Chem; 1998 Jan; 273(3):1733-40. PubMed ID: 9430720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pardaxin, a new pharmacological tool to stimulate the arachidonic acid cascade in PC12 cells.
    Abu-Raya S; Bloch-Shilderman E; Shohami E; Trembovler V; Shai Y; Weidenfeld J; Yedgar S; Gutman Y; Lazarovici P
    J Pharmacol Exp Ther; 1998 Dec; 287(3):889-96. PubMed ID: 9864269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.